Skip to content

Nuvalent, Inc. NUVL Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$14.7B+3.3%
Exelixis logo
ExelixisEXEL
$11.29B+10.1%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$19.27B+193%
Incyte logo
IncyteINCY
$18.73B+59.9%
ALN
Alnylam PharmaceuticalsALNY
$43.88B+25.6%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Computed from the period-end share price: $8.05B.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s market capitalization?
Nuvalent, Inc. (NUVL) reported market capitalization of $8.05B in Q1 2026.
How has Nuvalent, Inc.'s market capitalization changed year-over-year?
Nuvalent, Inc.'s market capitalization increased by 58.6% year-over-year, from $5.08B to $8.05B.
What is the long-term trend for Nuvalent, Inc.'s market capitalization?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s market capitalization has grown at a 70.7% compound annual growth rate (CAGR), from $919.33M to $7.81B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.